Mangoceuticals, Inc. (NASDAQ:MGRX) Stock Short Interest Report for October

Mangoceuticals, Inc. (NASDAQ:MGRX) was the target of a large decrease in short interest during the month of October. As of October 15th, there was short interest totaling 91,564 shares, a decrease of 79.1% from the September 30th total of 438,786 shares. Based on an average daily trading volume, of 739,664 shares, the short-interest ratio is presently 0.1 days. Approximately 0.5% of the shares of the company are short sold.

Mangoceuticals Stock Up 5.3%

MGRX stock opened at $0.24 on Tuesday. Mangoceuticals has a fifty-two week low of $0.16 and a fifty-two week high of $2.41. The firm’s 50-day simple moving average is $0.40 and its 200 day simple moving average is $0.42. The stock has a market cap of $5.27 million, a PE ratio of -0.24 and a beta of 1.98.

Mangoceuticals (NASDAQ:MGRX) last issued its quarterly earnings data on Thursday, August 13th. The company reported ($0.09) earnings per share for the quarter. The firm had revenue of $0.08 million during the quarter. Mangoceuticals had a negative net margin of 4,794.60% and a negative return on equity of 96.39%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on MGRX shares. Wall Street Zen upgraded shares of Mangoceuticals to a “sell” rating in a research note on Saturday, July 25th. Weiss Ratings restated a “sell (e+)” rating on shares of Mangoceuticals in a research note on Monday, September 21st. One research analyst has rated the stock with a Sell rating. According to data from MarketBeat, the company has an average rating of “Sell”.

Mangoceuticals Company Profile

Mangoceuticals, Inc, doing business as MangoRx, is a men’s health and wellness company that operates a direct-to-consumer telehealth platform. The company provides online access to healthcare consultations, prescription treatments and related products designed to address common men’s health concerns.

Its offerings have included treatments for erectile dysfunction and hair loss, as well as other wellness categories such as testosterone support and weight management. Products are generally marketed through the company’s digital platform and may be provided through prescriptions issued by independent licensed healthcare professionals, where appropriate.

Mangoceuticals serves customers in the United States through its online healthcare model.